J Immunol. 2026 Nov 2;215(11):vkag303. doi: 10.1093/jimmun/vkag303.
ABSTRACT
B-cell development in the bone marrow is a tightly regulated process requiring precise control of gene expression at both the transcriptional and post-transcriptional levels. Here, we identify the RNA-binding proteins PCBP1 and PCBP2 as critical regulators of early B lymphopoiesis with partially overlapping, dosage-sensitive functions. While a single deficiency of either Pcbp1 or Pcbp2 results in only a partial blockade at the pro-B to pre-B transition, their combined deletion causes a severe defect beginning at the pro-B stage and impairing subsequent development. Using single-cell RNA sequencing, we localize the major bottleneck to the pro-B VDJ A stage, which we propose represents cells undergoing D-JH rearrangement. Mechanistically, Pcbp1/2 deficiency triggers multifaceted cell-intrinsic defects, including downregulation of the Ebf1-dependent lineage program, mitochondrial dysfunction, and accumulation of proteotoxic stress. These defects converge to block early progenitor survival and expansion, ultimately preventing B cells from progressing beyond the pre-B stage. Consistently, single-axis interventions, such as providing a pre-rearranged BCR or scavenging reactive oxygen species (ROS), fail to restore development; ROS scavenging improves survival but not expansion. Our findings establish PCBP1 and PCBP2 as critical post-transcriptional regulators that couple metabolic fitness with lineage integrity during early B-cell development.
PMID:43033826 | DOI:10.1093/jimmun/vkag303